Monthly Archives: March 2021

PLBY Group (PLBY) Receives a Buy from Canaccord Genuity

Canaccord Genuity analyst Austin Moldow initiated coverage with a Buy rating on PLBY Group (PLBY – Research Report) today and set a price target of $28.00. The company’s shares closed last Tuesday at $17.40. According to TipRanks.com, Moldow is a

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (NASDAQ: TNDM) and Cormedix (NASDAQ: CRMD)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tandem Diabetes Care (TNDM – Research Report) and Cormedix (CRMD – Research Report) with bullish sentiments. Tandem Diabetes Care (TNDM) Oppenheimer analyst

Oppenheimer Reaffirms Their Buy Rating on Angion Biomedica (ANGN)

Oppenheimer analyst Justin Kim maintained a Buy rating on Angion Biomedica (ANGN – Research Report) today and set a price target of $38.00. The company’s shares closed last Tuesday at $17.99. According to TipRanks.com, Kim is a 4-star analyst with

HSBC Downgrades Banco Santander (Mexico) SA Institucion de Banca Multiple GrupoFinanciero Santander C (BSMX) to Hold

HSBC analyst HSBC downgraded Banco Santander (Mexico) SA Institucion de Banca Multiple GrupoFinanciero Santander C (BSMX – Research Report) to Hold yesterday. The company’s shares closed last Tuesday at $5.47, close to its 52-week high of $5.70. The word on

Analysts Offer Insights on Materials Companies: and RosCan Gold (Other OTC: RCGCF)

There’s a lot to be optimistic about in the Materials sector as 1 analysts just weighed in on and RosCan Gold (RCGCF – Research Report) with bullish sentiments. RosCan Gold (RCGCF) RosCan Gold received a Buy rating and a $0.80

Genel Energy (GEGYF) was Upgraded to a Buy Rating at Canaccord Genuity

Canaccord Genuity analyst Charlie Sharp upgraded Genel Energy (GEGYF – Research Report) to Buy today. The company’s shares closed last Monday at $2.50. According to TipRanks.com, Sharp is a 5-star analyst with an average return of 26.2% and a 59.9%